Program Description: 

This educational activity is based on case presentations and subsequent small group discussions of patients with hematologic malignancies that are being evaluated, treated and followed in the Department of Hematology and Oncology, and that have diagnostic or follow-up material evaluated in the Division of Hematopathology.  The goal of this multimodality approach is to ensure that the best patient care is being delivered by both Hematologists/Oncologists and Pathologists.

Key Words: CME, MCW, Pathology, Clinical Pathology, Molecular Pathology, Hematologic Neoplasms, Hematologic Tests, Hematologic Diseases, Morphological and Microscopic Findings, Diagnostic Techniques and Procedures, Clinical Laboratory Techniques, Hemic and Immune Systems, Differential Diagnosis, Pathological Processes, Neoplastic Cell Transformation

Target audience: 
Hematologists
Oncologists
Hematopathologists
Learning objectives: 

Learning objectives are identified for Hematologists/Oncologists and Hematopathologists.

Participants who engage in this educational intervention will be able to: 

Hematologists/Oncologists:

  • Identify appropriate ordering of expensive, ancillary diagnostic testing
  • Describe the salient morphologic, immunophenotypic, cytogenetic and molecular features of common hematologic malignancies 

Hematopathologists:

  • Discuss emergent therapeutic options and availability of clinical trials, and how they apply to patients diagnosed in our service
  • Utilize and constantly update themselves with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve outcomes and provide optimal patient care
Faculty & credentials: 

Activity Director

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

Alexandra Harrington, MD, MT(ASCP)CM
Professor of Pathology
Director of Hematopathology
Department of Pathology, MCW
Faculty Pillar Director, Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education

Planning Committee

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

John M. Astle, MD, PhD
Alexandra Harrington, MD, MT(ASCP)CM
Shannon M. Majewski, CMP, CMM, HMCC, VEMM
Lyndsey Runaas, MD

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

NameCompanyRole
Ehab Atallah, MDNovartisConsultant
Ehab Atallah, MDTakedaResearcher; Consultant
Ehab Atallah, MDAbbvieResearcher; Consultant
Ehab Atallah, MDAdaptive BiotechnologiesConsultant
Ehab Atallah, MDFoundation OneAdvisory Board
Ehab Atallah, MDCelgeneConsultant
Ehab Atallah, MDGenentechConsultant

 

Contact

Name: 
Shannon Majewski, CMP, CMM, HMCC, VEMM
Phone number: 
+1 (414) 805-6976
Email: 
smajewski@mcw.edu
Series date: 
01/01/2021 - 8:00am CST to 12/31/2021 - 9:00am CST
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of  Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 
MOC Part II Recognition Statement:
 
American Board of Pathology
American Board of Pathology SAMs
The Medical College of Wisconsin is a provider for Self-Assessment Modules as defined by the American Board of Pathology, and has designated this educational activity for a maximum of 1.0 SAM credits.
 
Participation shared with ABPath through PARS
Individual participants' information will be shared with ABPath through the ACCME Program and Activity Reporting System (PARS).   
 
American Board of Internal Medicine
Public Information About Activities Registered for ABIM MOC Recognition:
ACCME published information about accredited CME activities that have been registered for ABIM MOC via its CME Finder. CME Finder is a publicly available, online search tool that provides a one-stop resource for physician learners seeking to earn MOC points by participating in accredited CME.
 
Participation shared with ABIM through PARS:
Individual participants' information will be shared with ABIM through the ACCME Program and Activity Reporting System (PARS).
 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.
 
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit and ABPath MOC credit.
 
 
Group description: 
Hematologic Malignancy Conference 2021
Series location: 
Medical College of Wisconsin, Department of Pathology
9200 West Wisconsin Avenue
18 Headed Scope Room
Milwaukee, WI 53226
United States
See map: Google Maps

Sessions

Session Date
Hematologic Malignancy Conference: January 6, 2021 01/06/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: January 13, 2021 01/13/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: January 20, 2021 01/20/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: January 27, 2021 01/27/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: February 3, 2021 02/03/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: February 10, 2021 02/10/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: February 17, 2021 02/17/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: February 24, 2021 02/24/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: March 3, 2021 03/03/2021 - 8:00am to 9:00am CST
Hematologic Malignancy Conference: March 10, 2021 03/10/2021 - 8:00am to 9:00am CST

Pages